<i>Dendrobium officinale</i> Flower Extraction Mitigates Alcohol-Induced Liver Injury in Mice: Role of Antisteatosis, Antioxidative, and Anti-Inflammatory

Wu, Yu-Lin; Huang, Si-Han; He, Chun-Mei; Qiu, Bo; Liu, Jing-Jing; Li, Jia; Lin, Ying; Yu, Sheng-Lu; Wang, Hong-Feng; Zhang, Gui-Fang

doi:https://doi.org/10.1155/2020/1421853

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Special Issue

Standardization and Biological Properties of Functional Herbal Food

View this Special Issue

Research Article | Open Access

Volume 2020 | Article ID 1421853 | https://doi.org/10.1155/2020/1421853

Dendrobium officinale Flower Extraction Mitigates Alcohol-Induced Liver Injury in Mice: Role of Antisteatosis, Antioxidative, and Anti-Inflammatory

Yu-Lin Wu,¹Si-Han Huang,²Chun-Mei He,³Bo Qiu,²Jing-Jing Liu,¹Jia Li,¹Ying Lin,⁴Sheng-Lu Yu,⁵Hong-Feng Wang,³and Gui-Fang Zhang¹

Academic Editor: Li Zhang

Received04 Aug 2020

Revised05 Sept 2020

Accepted30 Sept 2020

Published23 Oct 2020

Abstract

The study aimed to evaluate the protective effect of Dendrobium officinale flower extraction (DOFE) on alcohol-induced liver injury and its probable mechanisms in mice. The chemical composition of DOFE was performed via UPLC/MS. Male Kunming mice were used to establish alcohol-induced liver injury models by oral gavage of 56% alcohol. Results showed that DOFE dramatically attenuated the increased serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), and triacylglycerol (TG). Meanwhile, hematoxylin and eosin and Oil Red O staining showed that DOFE attenuated degeneration, inflammatory infiltration, and lipid droplet accumulation. DOFE was also found to suppress the activity of malonaldehyde (MDA) and enhanced the level of glutathione (GSH) and the activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT) in the liver. The protection of DOFE against oxidative stress was associated with the downregulation of hepatic cytochrome P450 2E1 (CYP2E1) and upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), and NAD(P)H quinone oxidoreductase l (NQO1). Additionally, DOFE suppressed inflammation via downregulating Toll-like receptor-4 (TLR-4) and nuclear factor kappa-B P65 (NF-κB P65). Thus, DOFE exhibited a significant protective effect against alcohol-induced liver injury through its antisteatosis, antioxidative, and anti-inflammatory effect.

1. Introduction

Excess consumption of alcohol is a common cause of alcohol-induced liver disease (ALD) [1]. Each year, alcohol consumption contributes to about 3 million deaths according to an estimate by the World Health Organization. And the harmful use of alcohol is responsible for 5.1% of the global burden of disease [2]. Usually, ALD begins with simple hepatic steatosis and then develops to alcoholic steatohepatitis, fibrosis, and cirrhosis [3].

Previous studies have demonstrated that alcoholic liver injury is associated with steatosis, oxidative stress, and inflammation [4–6]. Normally, 90% of the alcohol is eliminated primarily in the liver [7]. Firstly, alcohol is converted into acetaldehyde in the presence of catalyst alcohol dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1). Then, the acetaldehyde is oxidized to acetic acid with the involvement of acetaldehyde dehydrogenase (ALDH2). Finally, the acetic acid is metabolized to carbon dioxide by the citric acid cycle [8]. However, the ability of liver to metabolize alcohol is limitary, and the alcohol-induced hepatotoxicity is mainly mediated through its conversion to acetaldehyde [9, 10]. On the one hand, the acetaldehyde can induce oxidative stress, decrease the amount of glutathione, and increase the production of reactive oxygen species (ROS) [8]. On the other hand, excess ROS induces the accumulation of lipid in hepatocytes, which leads to liver steatosis. In addition, overconsumption of alcohol activates Kupffer cells to generate a large amount of nuclear factor kappa-B which promotes the release of tumor necrosis factor-α (TNF-α) and other inflammatory cytokines [11, 12]. In another way, alcohol oxidation results in generation of nicotinamide adenine dinucleotide (NADH), which inhibits fatty acid oxidation but promotes fatty acid and triglyceride synthesis [3]. Therefore, preventing oxidative stress and inflammation would be an effective method in delaying the pathogenesis of alcohol-induced liver injury.

Clinically, the general treatment drugs of alcohol-induced liver injury include glucocorticoid, a phosphodiesterase inhibitor, and polyene phosphatidylcholine [13]. Although these drugs can reduce liver damage, they remain suboptimal with a marginal short-term survival benefit. Besides, they can increase the risk of infection and complications in patients. Therefore, it is greatly significant to investigate the pathogenesis of alcoholic liver disease and develop effective treatment medicine in the treatment and prevention of alcoholic liver disease. Recently, herbal medicines have attracted increasing attention in the treatment of alcoholic liver injury, due to the wide availabilities, multitarget actions, and low side effects [14–16]. Chinese herbal medicines of saponins from the leaves of Panax notoginseng, Camellia nitidissima, and phenol have been used to improve the alcohol-induced liver injury [6, 17, 18].

Dendrobium officinale Kimura et Migo (D. officinale), original food material and medical plant, is an important traditional Chinese herbal medicine [19]. The flowers of D. officinale have been traditionally used for tea making and cooking. In 2018, the Chinese authority approved the D. officinale flowers as a new food ingredient [20, 21]. The flowers of D. officinale have been shown that it would be a source containing a high amount of antioxidant phenolic components [22]. Besides, the flowers of D. officinale contained essential and nonessential amino acids [23], polysaccharides, and volatile components [24, 25]. Pharmaceutical studies revealed that D. officinale flowers exhibited DPPH radical scavenging activity and antihypertensive effect [21]. The animal studies demonstrated that D. officinale flowers protected against liver injury caused by an overactive thyroid axis [26], high glucose, and high-fat compound alcohol-induced hypertensive [27]. However, the effect of D. officinale flower extraction (DOFE) against alcohol-induced liver injury remains unknown. Therefore, we speculate that D. officinale flowers can protect against alcohol-induced liver injury.

This study aimed to systematically investigate whether DOFE exerted protective effects on alcohol-induced liver injury related to antisteatosis, antioxidative, and anti-inflammatory effects.

2. Materials and Methods

2.1. Materials and Chemicals

The dried flowers of D. officinale were provided by Guangdong Academy of Forestry (Guangzhou, China). Beijing Sorghum Spirit (56% vol) was purchased from Beijing Jingying Wine Co. Ltd. (Beijing, China), and bifendate (98%, 73536-69-3) was purchased from Shanghai Macklin Biochemical co. LTD (Shanghai, China). ALT (C009-2-1) detection kit, AST (C010-2-1) detection kit, hepatic lipid levels of TC (A111-1-1) detection kit, TG (A110-1-1) detection kit, GSH (A006-2) assay kit, GSH-Px (A005) assay kit, CAT (A007-1-1) assay kit, SOD (A001-1) assay kit, and MDA (A003-1) assay kit were obtained from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The enzyme-linked immunosorbent assay (ELISA) kits TNF-α (ml002095), IL-1β (ml063132), and IL-6 (ml063159) were purchased from Shanghai Enzyme Link Biotechnology Co. Ltd. (Shanghai, China). BCA kit (BB-3401) was purchased from Shanghai Beibo Biotechnology Co. Ltd. (Shanghai, China). A nuclear protein and cytoplasmic protein extraction kit (KGP150/KGP1100) was purchased from Nanjing Kaiji Biotechnology Development Co. Ltd. (Nanjing, China). CYP2E1 (DF6883), Nrf2 (AF0639), HO-1 (AF5393), NQO1 (DF6437), TLR4 (AF7017), NF-κB P65 (AF5006), Anti-Histone H3 antibodies (AF0863), and secondary antibodies (110191) were purchased from Affinity Biosciences (Inc., USA). Antibody against β-actin (ab8227) was purchased from Abcam (Cambridge, MA, USA). Reagents for Western Blotting were purchased from Bio-Rad (California Hercules, USA). Other materials in the experiments were analytically pure and obtained from local suppliers.

2.2. Extraction of DOFE

The dried Dendrobium officinale flowers were soaked 2 h in advance, refluxed thrice with 3-fold volumes of water for 1 h, filtered, and then concentrated by reducing pressure. The concentrated extract after filtration in the vacuum was freeze-dried. In this way, the Dendrobium officinale flowers extract (DOFE) was obtained and stored at 4°C.

2.3. Chemical Composition Analysis

The qualitative analysis of components in DOFE was carried out by a UPLC/qExactive-MS method. The analysis was performed on a UPLC instrument coupled with a Q Exactive spectrometer (Thermo Fisher, New York, United States) via an ESI ion source. Two hundred milligrams of DOFE was dissolved in 1 mL 80% methanol (HPLC grade) and then centrifuged at 20,000 × g, 4°C for 10 min to collect the supernatant. The supernatant was filtered through a filter (0.22 μm pore size) for analysis.

The sample was separated on a common RP-C18 column (2.1 mm × 150 mm, 1.8 μm; Welch). The column temperature was maintained at 35°C. The mobile phase consisted of water containing 0.1% (v/v) formic acid (A) and acetonitrile containing 0.1% (v/v) formic acid (B) at a flow rate of 0.3 mL/min. The gradient elution program was set as follows: 0–1 min, 98% A; 1–5 min, 98–80% A; 5–10 min, 80–50% A; 10–15 min, 50–20% A; 15–20 min, 20–5% A; 20–25 min, 5% A; 25–26 min, 5–98% A; 26–30 min, 98% A. The injection volume was 5 μL. High-purity nitrogen (N₂) and high-purity argon (Ar) were used as collision gas and desolvation gas, respectively. The capillary and auxiliary gas heater temperatures were 300°C and 350°C, respectively. The MS full scan range was 150–2000 m/z. All data collected were acquired and processed by the CD2.1 software (Thermo Fisher) and then retrieved and compared in the database (mzCloud, mzVault, ChemSpider).

2.4. Animal Experiments

The male Kunming mice, weighing 20 ± 2 g and aging 8 weeks old, were provided by the Laboratory Animal Center of Guangzhou University of Chinese Medicine (Guangzhou, China). All performance accorded with the Animal Experimental Ethics Committee of Guangzhou University of Chinese Medicine (Guangzhou, China, 20190531003).

The mice were adaptively raised for 7 days with random water and diet with a 12 h light/dark cycle under the controlled temperature (22 ± 2°C) and relative humidity (55% ± 5%). All mice were randomly assigned to the following six groups (n = 10): NC, MO, positive control group (PC, 150 mg/kg bifendate), a low dose of DOFE group (50 mg/kg), a moderate dose of DOFE group (100 mg/kg), and a high dose of DOFE group (200 mg/kg). Mice in the DOFE-treated groups and the PC group were orally given a corresponding dose of DOFE or bifendate. In contrast, in the NC and MO groups, mice were administered equal volumes of distilled water by gastric gavage. Two hours after each administration, all mice were intragastrically given 56% alcohol (10 mL/kg), except those in the NC group. The whole gavage procedure lasted for consecutive 10 days. On the last day, all mice fasted for 16 h. Blood subsequently was collected while fasting mice were anesthetized. Then, the mice were sacrificed, and the liver was carefully removed, weighed. The liver index was calculated according to the following calculation formula: The liver index = mice liver weight/mice weight × 100%. The hepatic tissues were harvested and washed with cold saline. Some tissues were fixed in 4% paraformaldehyde for histological evaluation and others were stored at−80°C for further analysis.

2.5. Histopathologic Evaluation

The liver tissues of those fixed in 4% paraformaldehyde were dehydrated and then embedded in paraffin. Then, samples were sectioned at 5 µm thickness and finally dyed with hematoxylin and eosin (H&E) routinely. Liver histopathologic changes were captured with an optical microscope at 200x magnification (E100, Nikon Corporation).

2.6. Oil Red O Staining

The frozen liver tissues were embedded in a frozen tissue matrix and then sectioned at 8 µm thickness. Finally, the sections were stained with Oil Red O (Sigma-Aldrich). The hepatic steatosis was observed from the Oil Red O staining by light microscopy (E100, Nikon Corporation).

2.7. Serum Biochemical Assays

The blood samples were kept at room temperature for 2 h and then centrifuged at 3000 rpm for 10 min at 4°C. Then, the serum was obtained, and the activities of ALT, AST, TC, and TG in the mice serum were determined by using commercials kits.

2.8. Liver Biochemical Assays

In brief, the liver tissues were kept in ice-cold saline (1 : 9, w/v) and then homogenized. The homogenate was centrifuged at 3000 rpm for 10 min at 4°C to separate the supernatant solution that was used to measure GSH, MDA levels, and GSH-PX, SOD, and CAT activities by commercial kits.

2.9. Enzyme-Linked Immunosorbent Assays (ELISA)

The liver tissues were thawed and then homogenized in cold PBS (1 : 9, w/v). After that, liver homogenates were centrifuged at 3000 rpm for 20 min. The assays of TNF-α, IL-1β, and IL-6 were performed by ELISA kits.

2.10. Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-PCR)

The total RNA was extracted from liver tissue samples with Trizol reagent and reverse transcribed into cDNA. RNA quantities were measured at 260 nm to 280 nm. And the purity of RNA was identified between 1.8 and 2.0. The expressions of CYP2E1, HO-1, NQO1, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in each sample were determined using HiScript® II Q RT SuperMix (+gDNA wiper) and ChamQ™ SYBR® qPCR Master Mix Kit. The mouse primer sequences were designed by using online primer design software (Sangon Biotech Co., Ltd., Shanghai), shown in Table 1. The amplification was performed, and the fluorescence intensity of the samples was determined by the monitor in real time. The gene expression of relative quantification was calculated using the 2^−ΔΔCq method using GAPDH as an internal reference.

2.11. Western Blotting Analysis

The liver tissue samples were homogenized in RIPA buffer with 1% of protease inhibitor cocktail and centrifuged at 14000 g for 10 min at 4°C. Then, the supernatant was removed and obtained total proteins. Besides, the protein of cytoplasmic and nucleus was extracted by the extraction kit (Thermo). And to determine the protein concentrations, the BCA Protein Assay Kit (Nanjing, Jiancheng) was used. The equivalent proteins of liver samples were separated by SDS-PAGE and then transferred to a polyvinylidene difluoride (PVDF) membrane. After that, the membranes with 5% skimmed milk were blocked under the room temperature for 1 h and then incubated with primary antibody of CYP2E1 (1 : 2000), Nrf2 (1 : 1000), HO-1 (1 : 1000), NQO1 (1 : 1000), TLR4 (1 : 3000), NF-κB P65 (1 : 1000), and β-actin (1 : 3000) at 4°C overnight, respectively. Next, each membrane with an HRP-conjugated secondary antibody was incubated under the room temperature for 2 h. Subsequently, the membranes with ECL reagent were visualized and detected by Western Blotting Detection System. The density of each band was analyzed using ImageJ software.

2.12. Statistical Analysis

All data were expressed as mean ± SD, and statistical analysis was performed with a one-way analysis of variance (ANOVA) using SPSS software 23.0. The figures were conducted using GraphPad Prism 8.0.1. The difference was considered statistically significant at the level of .

3. Results

3.1. Chemical Composition of DOFE

The total ion chromatogram of DOFE is shown in Figure 1, and the characterization of the compounds is presented in Table 2.

(a)

(b)

3.2. Effect of DOFE on Alcohol-Induced Liver Injury

To evaluate the effects of DOFE on alcohol-induced liver injury, liver index, hepatic histopathological changes, hepatic steatosis, and plasma markers were examined in alcohol-induced liver injury mice (Figure 2).

(a)

(b)

(c)

(d)

(e)

(f)

Hepatic cells had prominent nucleolus, complete pattern cytoplasm, and portal vein in the normal control (NC) group. However, the major histopathological change in the liver from the model (MO) group was lipid droplet accumulation. As shown in the cytosolic compartment and hepatic steatosis of liver sections stained with Oil Red O, the lipid vesicles were observed. However, fatty vesicles in either bifendate or DOFE treatment groups were much fewer than those of the MO group (Figure 2(a)). Compared with the NC group, the liver index in the MO group was remarkably increased by 32.6% (). However, DOFE (100 and 200 mg/kg) treatment significantly reversed the increase (, ), while there was no significant difference between the MO group and DOFE (50 mg/kg) treatment group (Figure 2(b)).

The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the MO group were significantly increased by 896.7% (15.4 ± 3.8 vs 153.0 ± 19.7) and 282.0% (33.4 ± 4.2 vs 127.4 ± 13.4), compared to the NC group. In contrast, these elevations were changed by the treatment with either bifendate or DOFE (all, ). The results indicated the hepatoprotective effects of DOFE on alcoholic liver injury. Surprisingly, DOFE (50 mg/kg) treatment decreased the serum ALT level in comparison to the MO group () (Figures 2(c) and 2(d)). In addition, alcohol exposure also dramatically increased serum total cholesterol (TC) and triacylglycerol (TG) contents by 54.0% and 145.4% compared with the NC group (both, ), and these elevations were significantly reversed by either bifendate or DOFE (100 and 200 mg/kg) treatments (all, ) (Figures 2(e) and 2(f)). These results demonstrated that DOFE could effectively protect against alcohol-induced liver injury.

3.3. Effect of DOFE on Alcohol-Induced Oxidative Stress

To evaluate the effects of DOFE on alcohol-induced oxidative stress, antioxidant enzyme and lipid peroxidation activities were examined (Figure 3). Alcohol induced the remarkable increase of malonaldehyde (MDA) production by 106.9% (1.2 ± 0.2 vs 2.5 ± 0.4, ). Consistently, the treatment of DOFE (100 and 200 mg/kg) significantly decreased the alcohol-induced hepatic lipid peroxidation (both, ). Conversely, the activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and the levels of glutathione (GSH) were significantly decreased in the alcohol treatment group compared with the NC group (all, ). The depletion of these antioxidants was significantly ameliorated by the treatment with 200 mg/kg DOFE (all, ). These data indicated that DOFE improved antioxidant capacity, reduced lipid peroxidation, and promoted antioxidant defense.

(a)

(b)

(c)

(d)

(e)

3.4. Effect of DOFE on the Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)/Heme Oxygenase-1 (HO-1)-Mediated Antioxidant Response

To understand the underlying mechanism of DOFE protecting against alcohol-induced oxidative stress, the protein expressions of CYP2E1 and antioxidant defense-related genes Nrf2, NAD(P)H quinone oxidoreductase l (NQO1), and HO-1 were examined by quantitative real-time polymerase chain reaction (qPCR) and Western Blotting Analysis (Figure 4). The protein expression and gene expression of CYP2E1 in the MO group increased 1.7-fold and 4.7-fold compared with the NC group (both, ). This elevation of the protein expression was significantly inhibited by 100 mg/kg DOFE and 200 mg/kg DOFE treatments (both, ). The elevation of the gene expression was significantly inhibited by all DOFE treatments (all, ). Similarly, the protein expression of nuclear Nrf2 in the MO group dramatically increased 4.4-fold when compared with the NC group (). Conversely, alcohol remarkably decreased the protein expressions of cytosol Nrf2, HO-1, and NQO1 by 56.1%, 48.1%, and 62.0%, respectively, compared with the NC group (all, ). The depletion of these proteins was significantly reversed by the treatments of 200 mg/kg DOFE (all, ). In addition, the gene expressions of HO-1 and NQO1 in the MO group dramatically decreased by 88.1% and 86.1% when compared with the NC group (both, ). These results clearly showed that the protective effects of DOFE against alcohol-induced liver injury are associated with upregulating the expression of CYP2E1 and antioxidant defense-related Nrf2, HO-1, and NQO1 genes.

(a)

(b)

(c)

(d)

3.5. Effect of DOFE on Alcohol-Induced Inflammation

To evaluate the effect of DOFE on alcohol-induced inflammation, the expressions of TNF−α, IL-1β, and IL-6 were determined (Figure 5). The levels of these cytokines were significantly higher in the MO group than those in the NC group. The results indicated that the liver suffered the alcohol-induced inflammatory response (all, ). Promisingly, DOFE significantly reduced the levels of TNF-α, IL-1β, and Interleukin-6 (IL-6) in the liver compared with the MO group (all, ). These results suggested that DOFE might improve alcohol-induced liver injury via suppressing the inflammatory response.

(a)

(b)

(c)

To examine the effect of DOFE on the alcohol-induced inflammatory response, the expressions of proteins related to the TLR4-mediated signaling pathway were examined (Figure 6). Alcohol caused a 2.2-fold increase in the protein expression of TLR4 compared with NC mice (). DOFE (100 mg/kg and 200 mg/kg) treatment significantly inhibited this alcohol-induced inflammation (both, ). Compared with the NC group, alcohol exposure also decreased the protein expression of its downstream NF-κB P65 by 46.5% and enhanced the nuclear NF-κB P65 by 1.6-fold (both, ), which were normalized by bifendate and 200 mg/kg DOFE treatments (all, ). The results revealed that DOFE reversed the upregulation of hepatic TLR4 and nuclear NF-κB P65 protein expression and the increase in the level of the inflammatory factor in the liver caused by alcohol. All these results demonstrated that DOFE might affect TLR4-mediated inflammatory response induced by alcohol exposure to reverse the alcohol-induced liver injury.

(a)

(b)

(c)

(d)

4. Discussion

Alcohol-induced liver injury is a common liver injury with a single and clear causative factor, the alcohol accumulation [11, 28]. When the liver is stimulated by alcohol, hepatocyte inflammation, necrosis, and steatosis can occur. Acetaldehyde, one of the alcoholic metabolites, can not only damage liver tissues directly but also destroy mitochondria and microtubules of most liver cells, resulting in excessive oxidation of unsaturated fatty acids, dysfunction of protein secretion, and oil accumulation [16, 29]. Meanwhile, excessive ethanol accumulation also can affect fat metabolism, resulting in fat accumulation in liver cells. In addition, alcohol metabolism produces a great number of reactive oxygen radicals, which lead to excessive oxidation of lipids [28, 29].

The serum ALT and AST levels are the most sensitive indicators of the liver damage and indirectly reflect the extent of the liver damage [30]. The increasing serum of ALT and AST would indicate liver cell damage or necrosis [31]. Our data suggested that the serum ALT and AST levels induced by alcohol in the DOFE group could be effectively downregulated. It is demonstrated that DOFE showed a good protective effect on alcohol-induced liver injury. Another important manifestation of alcoholic liver injury is lipid metabolism disorder, which is mainly manifested by the deposition of TG in the liver [28]. Previous studies have shown that the serum levels of TC and TG increased when the mice are given alcohol by gavage [32]. Our results also showed that alcohol exposure in mice could lead to the disorderliness of lipid metabolism and the increase of serum TC and TG levels. At the same time, DOFE could significantly reduce abnormal lipid levels, effectively decreasing the lipid accumulation caused by alcohol.

Alcohol metabolism produces many reactive oxygen radicals, and oxidative stress is an essential mechanism of alcoholic liver injury [33–35]. In the pathogenesis of alcohol-induced liver injury, oxidative stress plays a crucial role [36]. MDA, the end-product of excessive oxidation of lipids, is a general index of oxidative damage [37]. As an enzyme for catalyzing the conversion of superoxide anions to hydrogen peroxide and oxygen, SOD could maintain cellular redox balance and scavenge ROS [38]. GSH has been recognized as an important substrate in GSH-related antioxidation and detoxification [39]. GSH-Px specifically catalyzes the reduction reaction of GSH to peroxides to block the chain reaction of lipid peroxidation [39]. Therefore, increasing those enzymatic and nonenzymatic antioxidants may be conducive to relieve alcohol-induced oxidative stress [5, 40]. The results of this study demonstrated that DOFE could reduce the level of MDA and increase the activity of SOD, CAT, and GSH-PX activities and the GSH level. The hepatoprotective activity of DOFE could be returned to its contents of polyphenol, flavones, and alkaloids with their antioxidant characteristics. Studies indicated that rutin, schaftoside, vitexin, and quercetin could increase the antioxidant status in mice liver, which was consistent with our experimental results [41–43].

The CYP2E1, as one of the main members of this enzyme system, plays a crucial role in the oxidative stress mechanism in the alcoholic liver. The production of CYP2E1 will aggravate oxidative stress [44, 45]. Alcohol is a strong inducer of CYP2El [46]. In our study, the increased expression CYP2E1 gene and protein were significantly attenuated by the treatment of DOFE. To explore the mechanism of DOFE alleviating alcohol-induced liver injury, the expression of Nrf2 and its downstream protein HO-1 and NQO1 were also examined by Western Blotting and qPCR. Nrf2, a transcription factor, can induce many encoding detoxification enzymes of downstream genes and antioxidant proteins to relieve oxidative stress. Recently, Nrf2 has been recognized as a new target for the treatment of alcohol-induced liver injury [47–50]. Our results demonstrated that DOFE treatment inhibited the alcohol-induced elevation of cytosol Nrf2, HO-1, and NQO1 expressions. These results suggest that the protective effects of DOFE against alcohol-induced liver injury might reduce oxidative stress through the downregulation of CYP2E1 expression and the activation of the Nrf2/HO-1 pathway.

Evidence shows that inflammation is an essential factor which contributes to the initiation and progression of alcoholic liver disease [51]. Toll-like receptors (TLRs) have some protective effects when pathogens invade the body and activate signaling pathways that induce immune and proinflammatory gene expression [52]. Researches have shown that TLR4 plays a crucial role in many therapeutic targets for inflammation-related diseases [53]. Besides, previous studies have shown that mutant TLR4 mice [54], or mice deficient in TLR4 [22, 55], display a lower probability of alcohol-induced fatty liver disease. The activation of TLR4 can also upregulate levels of TNF-α, IL-1β, and IL-6 [56]. NF-κB P65 is activated by stimuli or cellular stress, such as TLRs, TNF-α, andIL-1β [57]. In this study, our results indicated that alcohol exposure increased the protein expressions of TLR4, nuclear NF-κB P65, and the levels of TNF-α, IL-1β, and IL-6. On the contrary, these increases were suppressed by DOFE. All these results demonstrated that DOFE inhibits TLR4/NF-κB-mediated inflammatory response induced by alcohol exposure.

5. Conclusions

Treatment with DOFE effectively protects against alcohol-induced liver injury. This protective effect might be associated with inhibiting steatosis, activating Nrf2/HO-1-mediated antioxidant defense, and suppressing TLR4/NF-κB -mediated inflammation. These findings also suggest that DOFE is a functional food for protecting against alcohol-induced liver injury (Figure 7).

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

Authors’ Contributions

Yu-Lin Wu and Si-Han Huan contributed equally to this work. Conceptualization was performed by Y.-L. W. and G. -F. Z. Methodology was carried out by J.-L. and C.-M. H. Software was provided by B. -Q. and Y. -L.. Validation was conducted by Y.-L. W., G. -F. Z., and H. -F. W. Formal analysis was carried out by S.-H. H. and S. -L. Y. Data curation was performed by Y. -L. W., S. -H. H., and J. -J. L. Writing and preparing the original draft was done by Y.-L. W. Reviewing and editing was done by S.-H. H. Visualization was carried out by S.-H. H. and C. -M. H. Supervision was performed by H.-F. W. and S. -L. Y. Funding acquisition was carried out by H.-F. W. and G. -F. Z.

Acknowledgments

This work was supported by grants from Forestry Science and Technology Innovational Specific Project of Guangdong Province (2017KJCX007); Guangdong Provincial Development Project of Strengthening Subjects (Agricultural Resources and Environment), Special Project on the Integration of Industry, Education and Research of Guangdong Province (2014B090902002); Project of National Survey of Traditional Chinese Medicine Resources from National Administration of Traditional Chinese Medicine (GZY-KJS-2018-004); Science and Technology Plan Projects of Guangdong Province in China (2015B020234008); and Natural Science Foundation of Guangdong Province in China (2014A030304059).

References

R. Parker, G. P. Aithal, U. Becker et al., “Natural history of histologically proven alcohol-related liver disease: a systematic review,” Journal of Hepatology, vol. 71, no. 3, pp. 586–593, 2019.
View at: Publisher Site | Google Scholar
WHO, Global Status Report on Alcohol and Health, World Health Organization, Geneva, Switzerland, 2018, https://www.who.int/topics/alcohol_drinking/zh/.
S. Jeon and R. Carr, “Alcohol effects on hepatic lipid metabolism,” Journal of Lipid Research, vol. 61, no. 4, pp. 470–479, 2020.
View at: Publisher Site | Google Scholar
X. Tang, R. Wei, A. Deng, and T. Lei, “Protective effects of ethanolic extracts from artichoke, an edible herbal medicine, against acute alcohol-induced liver injury in mice,” Nutrients, vol. 9, no. 9, p. 1000, 2017.
View at: Publisher Site | Google Scholar
R. Yuan, X. Tao, S. Liang et al., “Protective effect of acidic polysaccharide from Schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress,” Biomedicine & Pharmacotherapy, vol. 99, pp. 537–542, 2017.
View at: Publisher Site | Google Scholar
X. Sun, P. Wang, L. P. Yao et al., “Paeonol alleviated acute alcohol-induced liver injury via SIRT1/Nrf2/NF-κB signaling pathway,” Environmental Toxicology and Pharmacology, vol. 60, pp. 110–117, 2018.
View at: Publisher Site | Google Scholar
F. Stickel, C. Datz, J. Hampe, and R. Bataller, “Pathophysiology and management of alcoholic liver disease: update 2016,” Gut and Liver, vol. 11, no. 2, pp. 173–188, 2017.
View at: Publisher Site | Google Scholar
H. Y. Zhang, H. L. Wang, G. Y. Zhong, and J. X. Zhu, “Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury,” Pharmaceutical Biology, vol. 56, no. 1, pp. 594–611, 2018.
View at: Publisher Site | Google Scholar
A. Boye, Y. Zou, and Y. Yang, “Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: allies or enemies?” World Journal of Gastroenterology, vol. 22, no. 1, pp. 50–71, 2016.
View at: Publisher Site | Google Scholar
R. F. de Araujo Junior, V. B. Garcia, R. F. de Carvalho Leitao et al., “Carvedilol improves inflammatory response, oxidative stress and fibrosis in the alcohol-induced liver injury in rats by regulating kuppfer cells and hepatic stellate cells,” PLoS One, vol. 11, no. 2, Article ID e0148868, 2016.
View at: Publisher Site | Google Scholar
S. Wang, P. Pacher, R. C. De Lisle, H. Huang, and W. X. Ding, “A mechanistic review of cell death in alcohol-induced liver injury,” Alcoholism, Clinical Experimental Research, vol. 40, no. 6, pp. 1215–1223, 2016.
View at: Publisher Site | Google Scholar
W. Wei, L. Feng, W. R. Bao et al., “Structure characterization and immunomodulating effects of polysaccharides isolated from Dendrobium officinale,” Journal of Agricultural Food Chemistry, vol. 64, no. 4, pp. 881–889, 2016.
View at: Publisher Site | Google Scholar
A. K. Singal and V. H. Shah, “Current trials and novel therapeutic targets for alcoholic hepatitis,” Journal of Hepatology, vol. 70, no. 2, pp. 305–313, 2019.
View at: Publisher Site | Google Scholar
M. Singh, T. Hussain, H. Firdous et al., “Preclinical hepatoprotective effect of herbalism against ethanol induced hepatotoxicity: a review,” Current Drug Metabolism, vol. 19, no. 12, pp. 1002–1011, 2018.
View at: Publisher Site | Google Scholar
M. J. Guan, N. Zhao, K. Q. Xie, and T. Zeng, “Hepatoprotective effects of garlic against ethanol-induced liver injury: a mini-review,” Food and Chemical Toxicology, vol. 111, pp. 467–473, 2018.
View at: Publisher Site | Google Scholar
R. B. Ding, K. Tian, L. L. Huang et al., “Herbal medicines for the prevention of alcoholic liver disease: a review,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 457–465, 2012.
View at: Publisher Site | Google Scholar
R. B. Ding, K. Tian, Y. W. Cao et al., “Protective effect of panax notoginseng saponins on acute ethanol-induced liver injury is associated with ameliorating hepatic lipid accumulation and reducing ethanol-mediated oxidative stress,” Journal of Agricultural Food Chemistry, vol. 63, no. 9, pp. 2413–2422, 2015.
View at: Publisher Site | Google Scholar
X. Zhang, J. Feng, S. Su, and L. Huang, “Hepatoprotective effects of Camellia nitidissimaHepatoprotective effects of aqueous ethanol extract against CCl-induced acute liver injury in SD rats related to Nrf2 and NF-κB signalling,” Pharmaceutical Biology, vol. 58, no. 1, pp. 239–246, 2019.
View at: Publisher Site | Google Scholar
X. G. Xiang, A. Schuiteman, D. Z. Li et al., “Molecular systematics of Dendrobium (Orchidaceae, Dendrobieae) from mainland Asia based on plastid and nuclear sequences,” Molecular Phylogenetics Evolution, vol. 69, no. 3, pp. 950–960, 2013.
View at: Publisher Site | Google Scholar
D. Wang, B. Fan, Y. Wang, L. Zhang, and F. Wang, “Optimum extraction, characterization, and antioxidant activities of polysaccharides from flowers of Dendrobium devonianum,” International Journal of Analytical Chemistry, vol. 2018, Article ID 3013497, 8 pages, 2018.
View at: Publisher Site | Google Scholar
X. Zhang, S. Zhang, B. Gao et al., “Identification and quantitative analysis of phenolic glycosides with antioxidant activity in methanolic extract of Dendrobium catenatum flowers and selection of quality control herb-markers,” Food Research International, vol. 123, pp. 732–745, 2019.
View at: Publisher Site | Google Scholar
S. Inokuchi, H. Tsukamoto, E. Park, Z. X. Liu, D. A. Brenner, and E. Seki, “Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice,” Alcoholism, Clinical Experimental Research, vol. 35, no. 8, pp. 1509–1518, 2011.
View at: Publisher Site | Google Scholar
S. H. Lv, M. Xu, X. F. Zhang, J. J. Liu, and J. P. Si, “Polysaccharides, extracts, and amino acids in hybrid Dendrobium officinale flowers,” Journal of Zhejiang A&F University, vol. 33, no. 5, pp. 749–755, 2016.
View at: Publisher Site | Google Scholar
S. Zhang, Z. Qian, J. Liu, X. Zhang, and J. Si, “Relative molecular mass andmonosaccharide composition of polysaccharide in Dendrobium officinale flowers,” China Journal of Chinese Materia Medica, vol. 42, pp. 3919–3925, 2017.
View at: Publisher Site | Google Scholar
S. H. Lv, M. Xu, X. F. Zhang, J. J. Liu, and J. P. Si, “Studies on volatile constituents of 11 families of Dendrobium officinale flowers,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 22, no. 6, pp. 52–57, 2016.
View at: Google Scholar
S. S. Lei, G. Y. Lv, Z. W. Jin, B. Li, Z. B. Yang, and S. H. Chen, “Effect of extracts from Dendrobii ifficinalis flos on hyperthyroidism Yin deficiency mice,” China Journal of Chinese Materia Medica, vol. 40, no. 9, pp. 1793–1797, 2015.
View at: Publisher Site | Google Scholar
K. L. Liang, P. Fang, Q. Q. Shi et al., “Antihypertensive effect and mechanism of Dendrobium officinale flos on high-blood pressure rats induced by high glucose and high fat compound alcohol,” China Journal of Chinese Materia Medica, vol. 43, no. 1, pp. 147–153, 2018.
View at: Publisher Site | Google Scholar
L. Z. Kong, N. Chandimali, Y. H. Han et al., “Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease,” International Journal of Molecular Sciences, vol. 20, no. 11, p. 2712, 2019.
View at: Publisher Site | Google Scholar
A. Bertola, O. Park, and B. Gao, “Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin,” Hepatology, vol. 58, no. 5, pp. 1814–1823, 2013.
View at: Publisher Site | Google Scholar
Y. Guo, Q. Zhao, L. Cao, and B. Zhao, “Hepatoprotective effect of Gan Kang Yuan against chronic liver injury induced by alcohol,” Journal of Ethnopharmacology, vol. 208, pp. 1–7, 2017.
View at: Publisher Site | Google Scholar
C. Niu, Y. Sheng, E. Zhu, L. Ji, and Z. Wang, “Ferulic acid prevents liver injury induced by Diosbulbin B and its mechanism,” Bioscience Trends, vol. 10, no. 5, pp. 386–391, 2016.
View at: Publisher Site | Google Scholar
C. S. Lieber, “Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis,” Alcoholism, Clinical Experimental Research, vol. 34, no. 1, pp. 9–19, 2004.
View at: Publisher Site | Google Scholar
X. Wang, Y. Lan, Y. Zhu et al., “Hepatoprotective effects of Auricularia cornea var. Li. polysaccharides against the alcoholic liver diseases through different metabolic pathways,” Scientific Reports, vol. 8, no. 1, p. 7574, 2018.
View at: Publisher Site | Google Scholar
R. S. O’Shea, S. Dasarathy, and A. J. McCullough, “Alcoholic liver disease,” Hepatology, vol. 51, no. 1, pp. 307–328, 2010.
View at: Publisher Site | Google Scholar
D. Wu and A. I. Cederbaum, “Oxidative stress and alcoholic liver disease,” Seminars in Liver Disease, vol. 29, no. 2, pp. 141–154, 2009.
View at: Publisher Site | Google Scholar
H. Zhu, Z. Jia, H. Misra, and Y. R. Li, “Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence,” Journal of Digestive Diseases, vol. 13, no. 3, pp. 133–142, 2012.
View at: Publisher Site | Google Scholar
R. L. Smathers, J. J. Galligan, B. J. Stewart, and D. R. Petersen, “Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease,” Chemico-biological Interactions, vol. 192, pp. 107–112, 2011.
View at: Publisher Site | Google Scholar
C. R. White, T. A. Brock, L. Y. Chang et al., “Superoxide and peroxynitrite in atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 3, pp. 1044–1048, 1994.
View at: Publisher Site | Google Scholar
C. Hwang, A. J. Sinskey, and H. F. Lodish, “Oxidized redox state of glutathione in the endoplasmic reticulum,” Science, vol. 257, no. 5076, pp. 1496–1502, 1992.
View at: Publisher Site | Google Scholar
H. Zhao, Y. Lan, H. Liu et al., “Antioxidant and hepatoprotective activities of polysaccharides from spent mushroom substrates (laetiporus sulphureus) in acute alcohol-induced mice,” Oxidative Medicine and Cellular Longevity, vol. 2017, no. 5, Article ID 5863523, 12 pages, 2017.
View at: Publisher Site | Google Scholar
Z. H. Gao, H. B. Xu, and K. X. Huang, “Effects of rutin supplementation on antioxidant status and iron, copper, and zinc contents in mouse liver and brain,” Biological Trace Element Research, vol. 88, no. 3, pp. 271–279, 2002.
View at: Publisher Site | Google Scholar
M. J. Liu, G. H. Zhang, S. C. Wu et al., “Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor,” Journal of Ethnopharmacology, vol. 255, Article ID 112776, 2020.
View at: Publisher Site | Google Scholar
H. Yuan, S. Duan, T. Guan et al., “Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway,” European Journal of Pharmacology, vol. 880, Article ID 173160, 2020.
View at: Publisher Site | Google Scholar
M. A. Abdelmegeed, S. K. Ha, Y. Choi, M. Akbar, and B. J. Song, “Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases,” Current Molecular Pharmacology, vol. 10, no. 3, pp. 207–225, 2017.
View at: Publisher Site | Google Scholar
A. Ambade and P. Mandrekar, “Oxidative stress and inflammation: essential partners in alcoholic liver disease,” International Journal of Hepatology, vol. 2012, Article ID 853175, 9 pages, 2012.
View at: Publisher Site | Google Scholar
Y. Wang, G. Millonig, J. Nair et al., “Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease,” Hepatology (Baltimore, Md), vol. 50, no. 2, pp. 453–461, 2009.
View at: Publisher Site | Google Scholar
A. M. Bataille and J. E. Manautou, “Nrf2: a potential target for new therapeutics in liver disease,” Clinical Pharmacology & Therapeutics, vol. 92, no. 3, pp. 340–348, 2012.
View at: Publisher Site | Google Scholar
M. Ge, W. Yao, D. Yuan et al., “Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury,” Cell Death & Disease, vol. 8, Article ID e2841, 2017.
View at: Publisher Site | Google Scholar
W. Tang, Y.-F. Jiang, M. Ponnusamy, and M. Diallo, “Role of Nrf2 in chronic liver disease,” World Journal of Gastroenterology, vol. 20, no. 36, pp. 13079–13087, 2014.
View at: Publisher Site | Google Scholar
Y.-K. J. Zhang, K. C. Wu, and C. D. Klaassen, “Genetic activation of Nrf2 protects against fasting-induced oxidative stress in livers of mice,” PLoS One, vol. 8, no. 3, Article ID e59122, 2013.
View at: Publisher Site | Google Scholar
H. J. Wang, B. Gao, S. Zakhari, and L. E. Nagy, “Inflammation in alcoholic liver disease,” Annual Review of Nutrition, vol. 32, pp. 343–368, 2012.
View at: Publisher Site | Google Scholar
S. Divanovic, A. Trompette, S. F. Atabani et al., “Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105,” Nature Immunology, vol. 6, no. 6, pp. 571–578, 2005.
View at: Publisher Site | Google Scholar
L. Ma, X. Gong, G. Kuang, R. Jiang, R. Chen, and J. Wan, “Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice,” Biochemical Biophysical Research Communications, vol. 461, no. 2, pp. 230–236, 2015.
View at: Publisher Site | Google Scholar
T. Uesugi, M. Froh, G. E. Arteel, B. U. Bradford, and R. G. Thurman, “Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice,” Hepatology, vol. 34, no. 1, pp. 101–108, 2001.
View at: Publisher Site | Google Scholar
I. Hritz, P. Mandrekar, A. Velayudham et al., “The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88,” Hepatology, vol. 48, no. 4, pp. 1224–1231, 2008.
View at: Publisher Site | Google Scholar
Y. Yuan, X. Gong, L. Zhang et al., “Chlorogenic acid ameliorated concanavalin A-induced hepatitis by suppression of Toll-like receptor 4 signaling in mice,” International Immunopharmacology, vol. 44, pp. 97–104, 2017.
View at: Publisher Site | Google Scholar
E. Seki and R. F. Schwabe, “Hepatic inflammation and fibrosis: functional links and key pathways,” Hepatology, vol. 61, no. 3, pp. 1066–1079, 2015.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2020 Yu-Lin Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

663

Downloads

730

Citations